These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 34494298)

  • 21. The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy.
    Sengupta U; Nilson AN; Kayed R
    EBioMedicine; 2016 Apr; 6():42-49. PubMed ID: 27211547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.
    Xia M; Cheng X; Yi R; Gao D; Xiong J
    Mol Neurobiol; 2016 Jan; 53(1):455-471. PubMed ID: 25465238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
    Shankar GM; Li S; Mehta TH; Garcia-Munoz A; Shepardson NE; Smith I; Brett FM; Farrell MA; Rowan MJ; Lemere CA; Regan CM; Walsh DM; Sabatini BL; Selkoe DJ
    Nat Med; 2008 Aug; 14(8):837-42. PubMed ID: 18568035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity.
    Limegrover CS; LeVine H; Izzo NJ; Yurko R; Mozzoni K; Rehak C; Sadlek K; Safferstein H; Catalano SM
    J Neurochem; 2021 May; 157(4):1316-1330. PubMed ID: 33025581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities.
    Li S; Stern AM
    Mol Psychiatry; 2022 Aug; 27(8):3182-3191. PubMed ID: 35484241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
    J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformation-specific perturbation of membrane dynamics by structurally distinct oligomers of Alzheimer's amyloid-β peptide.
    Madhu P; Das D; Mukhopadhyay S
    Phys Chem Chem Phys; 2021 Apr; 23(16):9686-9694. PubMed ID: 33908427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isomerization of Asp7 in Beta-Amyloid Enhances Inhibition of the α7 Nicotinic Receptor and Promotes Neurotoxicity.
    Barykin EP; Garifulina AI; Kruykova EV; Spirova EN; Anashkina AA; Adzhubei AA; Shelukhina IV; Kasheverov IE; Mitkevich VA; Kozin SA; Hollmann M; Tsetlin VI; Makarov AA
    Cells; 2019 Jul; 8(8):. PubMed ID: 31349637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors.
    Alberdi E; Sánchez-Gómez MV; Cavaliere F; Pérez-Samartín A; Zugaza JL; Trullas R; Domercq M; Matute C
    Cell Calcium; 2010 Mar; 47(3):264-72. PubMed ID: 20061018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of NMDAR Antagonist on the Regulation of P-MARCKS Protein to Aβ
    Liu Y; Zhang P; Zheng Y; Yang C; Du T; Ge M; Chang X; Duan R; Ma G
    Neurochem Res; 2018 Oct; 43(10):2008-2015. PubMed ID: 30155805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.
    Kawarabayashi T; Shoji M; Younkin LH; Wen-Lang L; Dickson DW; Murakami T; Matsubara E; Abe K; Ashe KH; Younkin SG
    J Neurosci; 2004 Apr; 24(15):3801-9. PubMed ID: 15084661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.
    Smith LM; Strittmatter SM
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo.
    Fluharty BR; Biasini E; Stravalaci M; Sclip A; Diomede L; Balducci C; La Vitola P; Messa M; Colombo L; Forloni G; Borsello T; Gobbi M; Harris DA
    J Biol Chem; 2013 Mar; 288(11):7857-7866. PubMed ID: 23362282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.